HSTO — Histogen Cashflow Statement
0.000.00%
Last trade - 00:00- $1.28m
- -$4.32m
- $3.77m
- 19
- 31
- 19
- 12
Annual cashflow statement for Histogen, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -18 | -3 | -18.8 | -15 | -10.6 |
| Depreciation | |||||
| Non-Cash Items | 4.11 | 2.07 | 7.96 | 0.254 | 0.563 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -21.1 | -0.508 | -1.3 | 0.126 | 0.258 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -34.9 | -1.29 | -12.1 | -14.5 | -9.68 |
| Capital Expenditures | -0.066 | -0.152 | -0.049 | -0.241 | -0.216 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 30 | 0 | 11 | 0 | — |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 30 | -0.152 | 11 | -0.241 | -0.216 |
| Financing Cash Flow Items | -0.118 | — | 0.865 | -0.29 | 0 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.361 | 0.481 | 5.78 | 27.1 | 3.32 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.51 | -0.962 | 4.7 | 12.3 | -6.58 |